Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach

The emergence of multi-drug resistance in clostridium difficile is an urgent bio-threat associated with high morbidity and mortality. The availability of core genome sequences for pathogen strains provides the opportunity to rationally approach novel therapeutic targets. No preventive vaccine agains...

Full description

Bibliographic Details
Main Authors: Sara Aiman, Fawad Ali, Asad Zia, Muneeba Aslam, Zhongjie Han, Qurat ul Ain Farooq, Sulaiman Shams, Asifullah Khan, Chunhua Li
Format: Article
Language:English
Published: Aristotle University of Thessaloniki 2022-04-01
Series:Journal of Biological Research - Thessaloniki
Subjects:
Online Access:https://ejournals.lib.auth.gr/jbiolres/article/view/8481
_version_ 1811241293020397568
author Sara Aiman
Fawad Ali
Asad Zia
Muneeba Aslam
Zhongjie Han
Qurat ul Ain Farooq
Sulaiman Shams
Asifullah Khan
Chunhua Li
author_facet Sara Aiman
Fawad Ali
Asad Zia
Muneeba Aslam
Zhongjie Han
Qurat ul Ain Farooq
Sulaiman Shams
Asifullah Khan
Chunhua Li
author_sort Sara Aiman
collection DOAJ
description The emergence of multi-drug resistance in clostridium difficile is an urgent bio-threat associated with high morbidity and mortality. The availability of core genome sequences for pathogen strains provides the opportunity to rationally approach novel therapeutic targets. No preventive vaccine against C. difficile infections is available commercially to date. The core genome data of 63 complete genome sequences of C. difficile was utilized in the current study. A precise immune informatics layout has been followed for the identification of potential vaccine target proteins that are essential for the pathogen and show no homology to human as well as human gut flora proteome. Two antigenic outer membrane proteins were prioritized for the lead epitopes prediction based on the reverse vaccinology approach. The multi-epitope chimeric vaccines were engineered using lead T cell and B cell epitopes in combination with the adjuvant peptides and linker sequences involved in enhancing the immunogenic responses. Four vaccine constructs were designed from overlapping epitopes. Based on multiple physiochemical properties, including the antigenicity, allergenicity, solubility and, molecular docking scores, the vaccine construct V2 was finalized for further analysis. The in silico restriction and cloning analysis inferred the V2 vaccine construct cloning capability within the bacterial expression system. The molecular modeling and molecular dynamic simulation showed favorable molecular interaction of V2 in the host cell and ensured the molecular stability of the V2 prioritized construct. Multi-epitope-based vaccine designing is an effective approach to develop potential therapeutics with better safety, increased potency, and logistically viable. The chimeric vaccine construct prioritized in the current study speculates to effectively bind with human immune receptor proteins and possibly triggers a potent immune response against C. difficile invasion.
first_indexed 2024-04-12T13:34:16Z
format Article
id doaj.art-ef533d22b607489c910510482b7b9a1c
institution Directory Open Access Journal
issn 2241-5793
language English
last_indexed 2024-04-12T13:34:16Z
publishDate 2022-04-01
publisher Aristotle University of Thessaloniki
record_format Article
series Journal of Biological Research - Thessaloniki
spelling doaj.art-ef533d22b607489c910510482b7b9a1c2022-12-22T03:31:05ZengAristotle University of ThessalonikiJournal of Biological Research - Thessaloniki2241-57932022-04-0129010.26262/jbrt.v29i0.84817683Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approachSara AimanFawad AliAsad ZiaMuneeba AslamZhongjie HanQurat ul Ain FarooqSulaiman ShamsAsifullah KhanChunhua LiThe emergence of multi-drug resistance in clostridium difficile is an urgent bio-threat associated with high morbidity and mortality. The availability of core genome sequences for pathogen strains provides the opportunity to rationally approach novel therapeutic targets. No preventive vaccine against C. difficile infections is available commercially to date. The core genome data of 63 complete genome sequences of C. difficile was utilized in the current study. A precise immune informatics layout has been followed for the identification of potential vaccine target proteins that are essential for the pathogen and show no homology to human as well as human gut flora proteome. Two antigenic outer membrane proteins were prioritized for the lead epitopes prediction based on the reverse vaccinology approach. The multi-epitope chimeric vaccines were engineered using lead T cell and B cell epitopes in combination with the adjuvant peptides and linker sequences involved in enhancing the immunogenic responses. Four vaccine constructs were designed from overlapping epitopes. Based on multiple physiochemical properties, including the antigenicity, allergenicity, solubility and, molecular docking scores, the vaccine construct V2 was finalized for further analysis. The in silico restriction and cloning analysis inferred the V2 vaccine construct cloning capability within the bacterial expression system. The molecular modeling and molecular dynamic simulation showed favorable molecular interaction of V2 in the host cell and ensured the molecular stability of the V2 prioritized construct. Multi-epitope-based vaccine designing is an effective approach to develop potential therapeutics with better safety, increased potency, and logistically viable. The chimeric vaccine construct prioritized in the current study speculates to effectively bind with human immune receptor proteins and possibly triggers a potent immune response against C. difficile invasion.https://ejournals.lib.auth.gr/jbiolres/article/view/8481clostridium difficilereverse vaccinologyvaccine candidatesmulti-epitopeschimeric vaccine constructs
spellingShingle Sara Aiman
Fawad Ali
Asad Zia
Muneeba Aslam
Zhongjie Han
Qurat ul Ain Farooq
Sulaiman Shams
Asifullah Khan
Chunhua Li
Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
Journal of Biological Research - Thessaloniki
clostridium difficile
reverse vaccinology
vaccine candidates
multi-epitopes
chimeric vaccine constructs
title Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
title_full Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
title_fullStr Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
title_full_unstemmed Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
title_short Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
title_sort core genome mediated potential vaccine targets prioritization against clostridium difficile via reverse vaccinology an immuno informatics approach
topic clostridium difficile
reverse vaccinology
vaccine candidates
multi-epitopes
chimeric vaccine constructs
url https://ejournals.lib.auth.gr/jbiolres/article/view/8481
work_keys_str_mv AT saraaiman coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT fawadali coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT asadzia coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT muneebaaslam coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT zhongjiehan coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT quratulainfarooq coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT sulaimanshams coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT asifullahkhan coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach
AT chunhuali coregenomemediatedpotentialvaccinetargetsprioritizationagainstclostridiumdifficileviareversevaccinologyanimmunoinformaticsapproach